Results 251 to 260 of about 73,329 (379)

A Phosphoproteomic Analysis of Mycobacterial PknG-Mediated Host Immune Evasion. [PDF]

open access: yesJ Proteome Res
Baros-Steyl SS   +4 more
europepmc   +1 more source

Identification and Mechanisms of Osteocyte Subsets Involved in the Pathological Progression of Osteoporosis

open access: yesAdvanced Science, Volume 13, Issue 5, 27 January 2026.
Osteocyte heterogeneity in bone remains poorly understood. This study identifies six distinct osteocyte subsets in mice, revealing a key subpopulation (BHR‐Ocys) that drives bone loss in osteoporosis. BHR‐Ocys promote osteoclast‐mediated resorption via a novel Sema5a‐Plxna1 signaling axis.
Zengxin Jiang   +8 more
wiley   +1 more source

Global phosphoproteome analysis identifies PeVYV P4-induced host protein phosphorylation changes that facilitate viral proliferation. [PDF]

open access: yesBMC Plant Biol
Li S   +12 more
europepmc   +1 more source

Spatial Transcriptomics Unveils Landscape of Resistance to Concurrent Chemo‐Radiotherapy in Hypopharyngeal Squamous Cell Carcinoma: The Role of SPP1+ Macrophages

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Hypopharyngeal squamous cell carcinoma (SCC) is an aggressive malignancy with a poor prognosis, particularly in advanced stages. Concurrent chemoradiotherapy (CCRT) is frequently employed to preserve the larynx, but resistance to CCRT remains a significant clinical challenge.
Jungyoon Ohn   +6 more
wiley   +1 more source

EPSD 2.0: An Updated Database of Protein Phosphorylation Sites Across Eukaryotic Species. [PDF]

open access: yesGenomics Proteomics Bioinformatics
Chen M   +9 more
europepmc   +1 more source

[PHOSPHOPROTEINS].

open access: yesPostepy higieny i medycyny doswiadczalnej, 1996
openaire   +1 more source

The Potential of Phytochemicals to Overcome Multidrug Resistance in Metastatic Melanoma

open access: yesChemistry &Biodiversity, Volume 23, Issue 1, January 2026.
ABSTRACT Metastatic melanoma is the most lethal form of skin cancer, accounting for most skin cancer‐related deaths. Immunotherapies and targeted therapies have improved overall and progression‐free survival rates in metastatic melanoma patients. The effectiveness of these therapies decreases due to multidrug resistance (MDR).
Jacqueline Maphutha   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy